1 / 10

Biomarkers Market - Industry Set To Grow Positively

Biomarkers Market for Diagnostic Applications is Expected to Reach $30.6 Billion, Globally, by 2020. Read more at: https://www.alliedmarketresearch.com/biomarkers-market Diagnostic biomarkers continue to address challenges such as early and accurate diagnosis of most of the fatal diseases. Increasing advancements with extended applications of diagnostic biomarkers are only going to increase its significance in the field of diagnostics.Diagnostic biomarkers though are a great tool in molecular diagnostics, is facing challenges with respect to ethical and regulatory issues as these are relate to a genomic pattern of an individual which needs to be extremely confidential.

bethzhurst
Download Presentation

Biomarkers Market - Industry Set To Grow Positively

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Published Date: Dec 2013 No Of Pages: 151

  2. Introduction to Biomarkers Market Global biomarkers market for diagnostic applications such as risk assessment, molecular diagnostic, disease diagnosis, drug discovery & development, drug formulation, forensic and other such applications is set to reach about $30.6 billion in 2020 growing at CAGR of 16% from 2013 to 2020. Disease diagnostic remains the key application segment that is expected to reach $6.1 billion in 2020. Application of diagnostic biomarkers in forensics and molecular diagnostics is catching up quite significantly with latter expected to experience a growth rate of 17.6% during 2013 and 2020. Diagnostic biomarker technology is expected to change the scenario of drug development and medical practice, as technologies are metamorphosing from traditional pathophysiology/epidemiology approach to biomarker studies such as genomics and proteomic add the analysts.

  3. Biomarkers Market Key Segments • By Types • Biomarker of Exposure • Biomarker of Diseases • By Services • Sample Preparation • Assay Development • Biomarker Validation and Testing • Other Services

  4. Biomarkers Market Revenues Biomarkers market revenues share by segment, 2012 and 2020

  5. Biomarkers Market by Applications • Applications • Risk Assessment • Development of Molecular Diagnostic • Disease Diagnosis • Drug Discovery and Development • Drug Formulation • Forensic Application • Others (DNA Fingerprinting and Others)

  6. Key Benefits • The report offers an assessment and ranking of the factors that favor the biomarkers market growth and those factors which act as a hindrance for the growth of the market • Forecast period for estimating market size is from 2013 to 2020. Two historic years include 2011 and 2012 • The report identifies top investment pockets and offers an analysis of top winning strategies for diagnostic biomarker industry. • The report analyses the various strategies adopted by some of the key companies in the industry. • The report tracks and analyses key innovations and patents for biomarkers in the last five years

  7. Biomarkers Market By Geography North America, Europe, Asia Pacific, LAMEA

  8. Key Players Operating in Biomarkers Market Roche Diagnostic Limited (Switzerland) Siemens Healthcare (Germany) Abbott Laboratories Inc. (U.S.) Thermo Fisher Scientific, Inc. (U.S.) Agilent Technologies Inc. (U.S.) Bio-Rad Laboratories Inc. (U.S.) AushonBioSystem Inc. (U.S.) Epistem Ltd. (U.K.) G.E. Healthcare Inc. (U.K)

  9. Biomarkers Market Biomarkers offer a promising means to help improve diagnosis. Today, definitive diagnosis needs a surgical procedure that comes with no limitations reveals a researcher at Allied Market Research, studying the size and share of the biomarkers market. There are a range of biomarkers found effective in assessing organ status. However, they often fail to distinguish between patients with the disease and those with some other disorder. Thus the need for advanced imaging technology is growing for evaluating certain features, and is practical and affordable. Read more at: https://blog.alliedmarketresearch.com/is-biomarkers-all-set-to-take-the-scientific-applications-to-a-new-tangent-43

  10. Thank You! For More Details Visit us at https://www.alliedmarketresearch.com/biomarkers-market Follow Us On

More Related